NantKwest, Inc. (NASDAQ:NK) Downgraded to Hold at BidaskClub
BidaskClub downgraded shares of NantKwest, Inc. (NASDAQ:NK) from a buy rating to a hold rating in a research note published on Tuesday.
Other equities research analysts have also recently issued research reports about the company. Zacks Investment Research raised NantKwest from a hold rating to a buy rating and set a $7.75 price target on the stock in a report on Saturday, June 24th. Jefferies Group LLC set a $4.00 price target on NantKwest and gave the company a hold rating in a report on Monday, May 8th. ValuEngine raised NantKwest from a strong sell rating to a sell rating in a report on Wednesday, June 14th. Finally, Citigroup Inc. cut NantKwest from a neutral rating to a sell rating and set a $3.00 price target on the stock. in a report on Monday, May 15th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $10.79.
Shares of NantKwest (NASDAQ:NK) opened at 5.90 on Tuesday. NantKwest has a 1-year low of $2.71 and a 1-year high of $9.60. The firm’s 50-day moving average price is $6.99 and its 200 day moving average price is $4.88. The stock’s market capitalization is $484.71 million.
TRADEMARK VIOLATION WARNING: “NantKwest, Inc. (NASDAQ:NK) Downgraded to Hold at BidaskClub” was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/05/nantkwest-inc-nasdaqnk-downgraded-to-hold-at-bidaskclub.html.
In other news, Director Steve Gorlin sold 40,000 shares of NantKwest stock in a transaction that occurred on Tuesday, June 20th. The stock was sold at an average price of $7.78, for a total transaction of $311,200.00. Following the sale, the director now owns 409,725 shares of the company’s stock, valued at $3,187,660.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 70.19% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of NK. Renaissance Technologies LLC raised its position in NantKwest by 1,884.1% in the first quarter. Renaissance Technologies LLC now owns 486,100 shares of the biotechnology company’s stock worth $1,726,000 after buying an additional 461,600 shares in the last quarter. Vanguard Group Inc. raised its position in NantKwest by 8.4% in the first quarter. Vanguard Group Inc. now owns 2,082,706 shares of the biotechnology company’s stock worth $7,394,000 after buying an additional 160,510 shares in the last quarter. Alps Advisors Inc. bought a new position in NantKwest during the second quarter worth approximately $563,000. Schwab Charles Investment Management Inc. raised its position in NantKwest by 102.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 105,159 shares of the biotechnology company’s stock worth $799,000 after buying an additional 53,134 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in NantKwest during the second quarter worth approximately $365,000. Institutional investors and hedge funds own 19.77% of the company’s stock.
Receive News & Ratings for NantKwest Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantKwest Inc. and related companies with MarketBeat.com's FREE daily email newsletter.